Buy Lexicon Pharmaceuticals Stock | LXRX Stock Price & Latest News | Public.com
LXRX

Lexicon Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View Lexicon Pharmaceuticals (LXRX) stock trends here

    About LXRX

    Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthu...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.71
    0.26
    -0.2
    -0.65
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.14

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,01B
    Volume984,91k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.65
    1 Year Low$1.03
    Open$7.38
    High$7.62
    Low$7.16

    Buy any stock with any amount of money.

    Download the App
    Download the app